Crispr Therapeutics shares tumble after significant earnings miss
Thomas J. Shaw, President and CEO of Retractable Technologies Inc. (AMEX:RVP), recently acquired additional shares of the company's common stock. According to InvestingPro data, the company faces challenging conditions with a 24% year-over-year revenue decline and negative profitability in the last twelve months. According to a recent SEC filing, Shaw purchased 332 shares at an average price of $0.667 per share, totaling approximately $221. Following this transaction, Shaw directly owns 15,167,588 shares of Retractable Technologies. Additionally, he holds indirect ownership of 831,600 shares, with 500,000 of these shares under his investment power as a trustee for a family member. The transaction was conducted under a pre-established Rule 10b5-1 trading plan, adopted on August 22, 2024. Despite the company's stock declining 36% over the past year, InvestingPro analysis shows strong liquidity with a current ratio of 8.34, indicating robust short-term financial stability.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.